This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Lung Function and Patient Preference With QVA149 v...
Clinical trial

Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients (FAVOR)

Read time: 1 mins
Last updated:24th Apr 2014

The study is a multicenter, randomized, 2-period, open-label, two arm, cross-over study to show the superior effect of a 4 week treatment each with QVA149 versus tiotropium on lung function. Similarly, this study aims to evaluate patient preference after experiencing both treatment regimens in patients with a clinical diagnosis of COPD (GOLD 2013) and a moderate to severe airflow limitation who are symptomatic (defined as CAT score of at least 10) at screening despite being treated with tiotropium

Category Value
Study start date 2014-04-24

View full details